Stay updated with breaking news from Tracie oliver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12 month price […] ....
Commodore Capital LP lifted its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 24.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 575,000 shares of the biotechnology company’s stock after purchasing an additional 112,889 shares during the quarter. […] ....
Platinum Investment Management Ltd. purchased a new stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 76,208 shares of the biotechnology company’s stock, valued at approximately $1,936,000. Platinum Investment Management Ltd. owned approximately […] ....
Russell Investments Group Ltd. cut its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 8.3% in the first quarter, Holdings Channel.com reports. The firm owned 227,898 shares of the biotechnology company’s stock after selling 20,711 shares during the quarter. Russell Investments Group Ltd.’s holdings in Arrowhead Pharmaceuticals were worth $5,789,000 as of its […] ....
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expected to Post FY2024 Earnings of ($3.69) Per Share theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.